Search companies

Live

Tuesday, 17 November 2026 · 583 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Bio-Gene Technology proposes 6.5 million incentive options for directors and management

BGT: $0.013 -23.53% · MC: $7M

Bio-Gene Technology proposes issuing 6.5 million options expiring in 2029 as incentives for directors and management. The proposed issue includes 4.5 million options for directors, subject to shareholder approval at the AGM, and 2 million for management, which do not require approval.

Source announcements: 2026-10-28 10:56 to 2026-10-28 10:56 Sydney time
Story updated 2026-10-28 11:14 Sydney time
SourcesProposed issue of securities - BGT
Comments